
Gossamer Bio Investor Relations Material
Latest events

Collaboration with Chiesi Farmaceutici S.p.A. 2024
Gossamer Bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Gossamer Bio Inc
Access all reports
Gossamer Bio, Inc. is a U.S.-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in immunology, inflammation, and oncology. The company’s research pipeline targets diseases with unmet medical needs, including autoimmune disorders, inflammatory conditions, and cancer. Gossamer Bio leverages its scientific expertise to advance novel drug candidates through clinical trials, aiming to deliver effective treatment options for complex and chronic illnesses. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
GOSS
Country
🇺🇸 United States